Novartis Ophthalmics granted exclusive rights for development and commercialization of the first pharmaceutical treatment of myopia from Valley Forge
New antimuscarinic drug halves progression of myopia over 12 months in children, study shows
Is There Anything We Can do to Stop, Reverse or Slow This Myopic Progression?
EyeWorld Magazine: The near view on non-surgical treatment for pediatric myopia
Ophthalmology Review: The near view on non-surgical treatment for pediatric myopia Atropine and Pirenzepine for nearsightedness
NTU Myopia research
NTU Myopia treatment
vhcy myopia
alcon drugs
Friday, December 02, 2005
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment